Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Carnitine on Oxidative Stress from IV Iron in CKD Patients
NCT02312414Unknown
- Sponsor
- Nazareth Hospital
- Start
- Oct 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of levocarnitine in anemia (2 arms), sponsored by Nazareth Hospital. Primary endpoints: Advanced Oxidation Protein Products at 1 month and Neutrophil Gelatinase-Associated Lipocalin at 1 month. Status: unknown.
02
Drugs
levocarnitine
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02312414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02312414.